Results 191 to 200 of about 12,657,081 (210)
Cross‐tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease
Abstract INTRODUCTION Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD), but its contribution to disease pathogenesis remains incompletely understood. METHODS Here, we integrate proteomic profiling of plasma (n = 9028), cerebrospinal fluid (n = 1099), dorsolateral prefrontal cortex (n = 720), and ...
Artur Shvetcov +19 more
wiley +1 more source
Adults 40 years of age and older have been shown to be hypo-responsive immunologically to the currently available hepatitis B virus (HBV) vaccines. Three intramuscular doses of a Toll-like receptor 9 agonist, 1018 immunostimulatory sequence (1018 ISS ...
Mong Cho, Sang Hoon Ahn, Dong Joon Kim
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
Journal of Hepatology, 2021Gerardo Nardone +2 more
exaly
The mRNA COVID-19 vaccine – A rare trigger of autoimmune hepatitis?
Journal of Hepatology, 2021Jonathan Rigby, Cathy McShane
exaly
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Nassim Hammoudi +2 more
exaly
The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E
Vaccine, 2007Chen Dong
exaly
Immune response to hepatitis A vaccine in patients with HIV
Vaccine, 2019Emil Reisinger +2 more
exaly
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
Vaccine, 2003William Blackwelder +2 more
exaly

